What to know about the STD that could become the next superbug
Mycoplasma genitalium was first discovered in the early 1980s.
ConclusionsThe pernicious effect of high vancomycin MIC disappears in the absence of a predominant use of this antibiotic. However, a high daptomycin MIC in MRSA bacteraemia is associated with higher mortality in patients with bacteraemia, irrespective of antimicrobial treatment choice.
ConclusionThe large variety of cultivable, clinically important bacteria, especially the genetically related MDR S. aureus, K. pneumoniae, Acinetobacter spp. and Enterobacter spp., from various sampling sites indicated that the surfaces and fomites in the hospital were potential exogenous sources of nosocomial infection in the hospital.
Authors: Tang X, Xiao M, Zhuo C, Xu Y, Zhong N Abstract Background: With the different situation for clinical antibiotic usage and its management in different regions and medical institutions, the antimicrobial resistance varied in different level. However, the epidemiological data of multi-drug resistant (MDR) strains from the department of respiration is limited. Thus, this study aims to investigate the epidemiology of bacteria isolated from inpatients of respiratory departments, and analyze the distribution variation of major multi-drug resistant bacteria in China. Methods: Based on data from China Antimicro...
The British Association of Sexual Health and HIV has produced its first guideline for the diagnosis of a little known but common sexually transmitted infection called Mycoplasma genitalium, to address concerns that MG has the potential to become a “superbug” within 10 years.
Kerstin Rosen, Uwe Roesler, Roswitha Merle, Anika Friese
Conclusion: Our results revealed that ST clones associated with healthcare-associated MRSA (HA-MRSA) are actively circulating among nasal carriage in our healthcare setting, and thus, effective infection control policies are needed to reduce nasal carriage in healthcare settings. PMID: 29997747 [PubMed]
You ’ve probably never heard of Mycoplasma genitalium, even though it’s one of the most prevalent. Here’s what you need to know
Publication date: Available online 11 July 2018Source: Journal of Trace Elements in Medicine and BiologyAuthor(s): Katherin Steffy, G. Shanthi, Anson. S. Maroky, S. SelvakumarAbstractMultidrug resistance in bacterial strains has become the greatest challenge for healthcare professionals for treating non-healing ulcers such as diabetic foot infections (DFI). Plant-mediated synthesis of S. nux-vomica–ZnO nanocomposite appears as a potential new alternative therapeutic agent that might be capable of tackling antibiotic-resistant bacterial pathogens and for treating a non-healing ulcer. The aim of the study was to invest...
ConclusionTedizolid phosphate 200 mg for 7–14 days was a favored treatment option for patients with severe/complex ABSSSIs, and was effective following previous treatment failure or in late-onset infections.FundingEditorial assistance and the article processing charges were funded by Bayer AG, Berlin, Germany.